Rep. Tom Reed, R-N.Y., reintroduced a bill that would require publicly funded research results to be reported to ClinicalTrials.gov whether the outcome is positive or negative. Researchers who fail to comply would be ineligible for future grants. "It's vitally important all trial results are shared so that we might better understand the results to provide better care and advance our shared goal of finding a cure," Reed said, emphasizing the bill's importance for cancer research.

Full Story:

Related Summaries